Monte Rosa Therapeutics (NASDAQ:GLUE) Downgraded by Wells Fargo & Company to “Equal Weight”
Wells Fargo & Company cut shares of Monte Rosa Therapeutics (NASDAQ:GLUE – Free Report) from an overweight rating to an equal weight rating in a research note released on Thursday morning, MarketBeat reports. The firm currently has $11.00 price target on the stock, down from their prior price target of $14.00. Separately, Wedbush restated an […]
More Stories
Falcon Gold (CVE:FG) Trading Up 25% – Should You Buy?
Falcon Gold Corp. (CVE:FG – Get Free Report) shot up 25% on Friday . The company traded as high as...
At Least 2 Dead, 60 Injured in Germany After Car Plows Into Christmas Market
By Bill Pan A car drove into a crowd at a Christmas market in the German city of Magdeburg on...
Volkow Ben Sells 25,100 Shares of Urgent.ly Inc. (NASDAQ:ULY) Stock
Urgent.ly Inc. (NASDAQ:ULY – Get Free Report) Director Volkow Ben sold 25,100 shares of the stock in a transaction dated...
Xtrackers RREEF Global Natural Resources ETF (NASDAQ:NRES) to Issue Quarterly Dividend of $0.15
Xtrackers RREEF Global Natural Resources ETF (NASDAQ:NRES – Get Free Report) announced a quarterly dividend on Thursday, December 19th,NASDAQ Dividends...
Schwab Ultra-Short Income ETF (NYSEARCA:SCUS) to Issue $0.08 Dividend
Schwab Ultra-Short Income ETF (NYSEARCA:SCUS – Get Free Report) declared a dividend on Thursday, December 19th,NASDAQ Dividends reports. Investors of...
Regency Affiliates, Inc. to Issue Quarterly Dividend of $0.08 (OTCMKTS:RAFI)
Regency Affiliates, Inc. (OTCMKTS:RAFI – Get Free Report) announced a quarterly dividend on Thursday, December 19th,NASDAQ Dividends reports. Stockholders of...